Drugs / Mesenchymal Stem Cells from Wharton´s jelly
Mesenchymal Stem Cells from Wharton´s jelly
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT07542067 | May 2024 → Jun 2025 | pulmonary fibrosis, pulmonary hypertension, pulmonary systemic sclerosis | Fundación Neumologica Colombiana | Completed | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT04432545 | — | pulmonary fibrosis, pulmonary hypertension, pulmonary systemic sclerosis | Universidad de la Sabana | Available | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mesenchymal Stem Cells from Wharton ́s jelly | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04432545 ↗ |
| Modality | Cell therapy | “allogeneic mesenchymal stromal cell infusion” NCT04432545 ↗ |
| Route | Intravenous | “The administration will be intravenously” NCT04432545 ↗ |